KaRa MINDS
Macquarie Park, New South Wales, Australia
Mental health service in Macquarie Park, New South Wales
35/41 Waterloo Rd, Macquarie Park NSW 2113
About KaRa MINDS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Anavex Life Sciences Corp.
3
Athira Pharma
2
AZTherapies, Inc.
1
Actinogen Medical
1
Biogen
1
Cassava Sciences, Inc.
1
Eisai Inc.
1
Eli Lilly and Company
1
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
1
Hoffmann-La Roche
1
Inmune Bio, Inc.
1
Clinical Trials at KaRa MINDS
During the past decade, KaRa MINDS conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
2015-09-15
2020-11-18
Completed
620
A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
2017-03-23
2019-03-15
Completed
185
Deferiprone to Delay Dementia (The 3D Study)
2018-01-19
2023-09-01
Active, not recruiting
171
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
2019-03-27
2027-09-15
Active, not recruiting
1,906
A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's
2019-11-20
2021-09-01
Completed
20
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "KaRa MINDS" #1 sponsor was "Anavex Life Sciences Corp." with 3 trials, followed by "Athira Pharma" with 2 trials
sponsored, "AZTherapies, Inc." with 1 trials sponsored, "Actinogen Medical" with 1 trials sponsored and "Biogen"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KaRa MINDS"
#1 collaborator was "Anavex Australia Pty Ltd." with 3 trials as a collaborator, "Anavex Germany GmbH" with 3 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Anavex Canada Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at KaRa MINDS
According to Clinical.Site data, the most researched conditions in "KaRa MINDS" are
"Alzheimer Disease" (8 trials), "Alzheimer's Disease" (2 trials), "Alzheimers Disease" (1 trials), "Dementia of Alzheimer Type" (1 trials) and "Dementia, Alzheimer Type" (1 trials). Many other conditions were trialed in "KaRa MINDS" in a lesser frequency.
Clinical Trials Intervention Types at KaRa MINDS
Most popular intervention types in "KaRa MINDS" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "ANAVEX2-73" (2 trials), "ATH-1017" (2 trials), "ALZT-OP1a" (1 trials) and "ALZT-OP1b" (1 trials). Other intervention names were less common.
Clinical Trials Genders at KaRa MINDS
The vast majority of trials in "KaRa MINDS" are
15 trials for "All" genders.
Clinical Trials Status at KaRa MINDS
Currently, there are NaN active trials in "KaRa MINDS".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in KaRa MINDS,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in KaRa MINDS, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".